Skip to search formSkip to main contentSkip to account menu

HMR 1826

Known as: HMR-1826 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
The doxorubicin prodrug HMR-1826 shows comparable antitumour activity to doxorubicin and liposomal doxorubicin
  • 2000
  • Corpus ID: 195130596
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)